Found: 5
Select item for more details and to access through your institution.
Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 685, doi. 10.3390/vaccines9070685
- By:
- Publication type:
- Article
ImmunizziAMO: A School-Based Field Trial to Teach New Generations the Importance of Vaccination through Games and to Fight Vaccine Hesitancy in Italy.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 280, doi. 10.3390/vaccines8020280
- By:
- Publication type:
- Article
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1221587
- By:
- Publication type:
- Article
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01090-6
- By:
- Publication type:
- Article